{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:36:19Z","timestamp":1770435379557,"version":"3.49.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.hoc.2008.07.011","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T09:21:01Z","timestamp":1225185661000},"page":"883-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Marginal Zone Lymphomas"],"prefix":"10.1016","volume":"22","author":[{"given":"Emanuele","family":"Zucca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Stathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2008.07.011_bib1","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.hoc.2008.07.011_bib2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The Non-Hodgkin's Lymphoma Classification project: a clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib3","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"157","article-title":"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"Isaacson","year":"2001"},{"key":"10.1016\/j.hoc.2008.07.011_bib4","series-title":"MALT lymphomas","first-page":"17","article-title":"MALT lymphoma: pathology","author":"Pozzi","year":"2004"},{"key":"10.1016\/j.hoc.2008.07.011_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V96.2.410.014k22_410_419","article-title":"The gastric marginal zone B-cell lymphoma of MALT type","volume":"96","author":"Zucca","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1365-2141.1997.1392954.x","article-title":"Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process","volume":"97","author":"Bertoni","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2008.07.011_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2008.07.011_bib8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-122-10-199505150-00006","article-title":"Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue","volume":"122","author":"Roggero","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2008.07.011_bib9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(95)90113-2","article-title":"Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group","volume":"345","author":"Bayerdorffer","year":"1995","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2008.07.011_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/annonc\/8.suppl_2.S37","article-title":"Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies","volume":"8","author":"Montalban","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jnci\/89.18.1350","article-title":"Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma","volume":"89","author":"Neubauer","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2008.07.011_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/10428199709050889","article-title":"Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma","volume":"26","author":"Pinotti","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.hoc.2008.07.011_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.1997.v113.pm9322502","article-title":"Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group","volume":"113","author":"Sackmann","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hoc.2008.07.011_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7326\/0003-4819-131-2-199907200-00003","article-title":"Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial","volume":"131","author":"Steinbach","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2008.07.011_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.48.3.297","article-title":"Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment","volume":"48","author":"Ruskone-Fourmestraux","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2008.07.011_bib16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/gut.48.4.454","article-title":"Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori","volume":"48","author":"Nakamura","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2008.07.011_bib17","first-page":"11","article-title":"Are antibiotics the treatment of choice for gastric lymphoma?","volume":"3","author":"Zucca","year":"2004","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.hoc.2008.07.011_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(00)80233-6","article-title":"Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin","volume":"31","author":"Roggero","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2008.07.011_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2008.07.011_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Lecuit","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.011_bib21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0140-6736(92)90280-G","article-title":"High incidence of primary gastric lymphoma in northeastern Italy","volume":"339","author":"Doglioni","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2008.07.011_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<3::AID-CNCR2>3.0.CO;2-P","article-title":"Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237\u00a0patients","volume":"79","author":"Nakamura","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.07.011_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2008.07.011_bib24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","article-title":"Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis","volume":"102","author":"Radaszkiewicz","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hoc.2008.07.011_bib26","series-title":"MALT lymphomas","first-page":"60","article-title":"MALT lymphoma: sites of presentations, clinical features and staging procedures","author":"Thieblemont","year":"2004"},{"key":"10.1016\/j.hoc.2008.07.011_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI27476","article-title":"Delving deeper into MALT lymphoma biology","volume":"116","author":"Bertoni","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2008.07.011_bib28","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1200\/JCO.2005.05.011","article-title":"Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma","volume":"23","author":"Farinha","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","article-title":"T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10","volume":"98","author":"Liu","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of Rituximab in gastric marginal zone Non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy","volume":"23","author":"Martinelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000079502","article-title":"Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma","volume":"66","author":"Streubel","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.hoc.2008.07.011_bib32","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2008.07.011_bib33","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1200\/JCO.2006.05.6150","article-title":"Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma","volume":"24","author":"Sagaert","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib34","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib35","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108\u00a0patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib36","first-page":"454","article-title":"Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma","volume":"83","author":"Raderer","year":"2000","journal-title":"Br\u00a0J\u00a0Cancer"},{"key":"10.1016\/j.hoc.2008.07.011_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/asheducation-2001.1.241","article-title":"MALT Lymphomas","author":"Cavalli","year":"2001","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.hoc.2008.07.011_bib38","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood.V88.12.4445.bloodjournal88124445","article-title":"Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma","volume":"88","author":"Du","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib39","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood.V90.10.4071","article-title":"Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone","volume":"90","author":"Du","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib40","first-page":"919","article-title":"Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas","volume":"150","author":"Drillenburg","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hoc.2008.07.011_bib41","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib42","first-page":"218","volume":"153","author":"Musshoff","year":"1977","journal-title":"Strahlentherapie"},{"key":"10.1016\/j.hoc.2008.07.011_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1008392022152","article-title":"Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an International survey","volume":"10","author":"de Jong","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.2006.06444.x","article-title":"Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?","volume":"136","author":"Ferrucci","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2008.07.011_bib45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/1042819021000035680","article-title":"Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976\u20132001","volume":"44","author":"Thieblemont","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.hoc.2008.07.011_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdi093","article-title":"FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases","volume":"16","author":"Beal","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib47","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","author":"Elstrom","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000070290","article-title":"18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma","volume":"64","author":"Hoffmann","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.hoc.2008.07.011_bib49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","article-title":"Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma","volume":"5","author":"Rohatiner","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib50","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","article-title":"T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication","volume":"122","author":"Liu","year":"2002","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2008.07.011_bib51","first-page":"III19","article-title":"Helicobacter and gastric MALT lymphoma","volume":"50","author":"Stolte","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2008.07.011_bib52","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1572-0241.2003.07424.x","article-title":"Gastric mucosa-associated lymphoid tissue lymphoma","volume":"98","author":"Ahmad","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hoc.2008.07.011_bib53","series-title":"MALT lymphomas","first-page":"81","article-title":"Gastric MALT lymphomas: the role of antibiotics","author":"Conconi","year":"2004"},{"key":"10.1016\/j.hoc.2008.07.011_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","article-title":"Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series","volume":"53","author":"Fischbach","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2008.07.011_bib55","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","article-title":"Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication","volume":"23","author":"Wundisch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib56","doi-asserted-by":"crossref","unstructured":"Chini C, Pinotti G, Stathis A, et\u00a0al. Long term outcome of gastric MALT lymphoma patients treated with Anti-Helicobacter (antibiotic and proton-pump inhibitor) regimens. Blood (presented at the ASH Annual Meeting Abstracts) 110:110:Abstract 2583, 2007.","DOI":"10.1182\/blood.V110.11.2583.2583"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2008.07.011_bib57","doi-asserted-by":"crossref","first-page":"ii70","DOI":"10.1093\/annonc\/mdn094","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"19","author":"Zucca","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib58","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1200\/JCO.2005.05.018","article-title":"State-of-the-art therapeutics: marginal-zone lymphoma","volume":"23","author":"Bertoni","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib59","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1572-0241.1998.00684.x","article-title":"Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology","volume":"93","author":"Howden","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hoc.2008.07.011_bib60","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood.V99.7.2541","article-title":"Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial","volume":"99","author":"Bertoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib61","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1200\/JCO.2001.19.6.1600","article-title":"Persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa- associated lymphoid tissue B-cell lymphoma","volume":"19","author":"Thiede","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.hoc.2008.07.011_bib62","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdi277","article-title":"Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study","volume":"16","author":"Montalban","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00428-005-1217-3","article-title":"Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue","volume":"446","author":"de Mascarel","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.hoc.2008.07.011_bib64","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0016-5085(99)70483-X","article-title":"Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibiotics","volume":"117","author":"Isaacson","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hoc.2008.07.011_bib65","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","article-title":"Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series","volume":"56","author":"Fischbach","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2008.07.011_bib66","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/jnci\/dji277","article-title":"Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma","volume":"97","author":"Chen","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2008.07.011_bib67","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2008.07.011_bib68","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1572-0241.2002.05460.x","article-title":"Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome","volume":"97","author":"Levy","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hoc.2008.07.011_bib69","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1182\/blood.V95.12.4014","article-title":"Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection","volume":"95","author":"Alpen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.2005.081117","article-title":"Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H. pylori eradication","volume":"55","author":"Ye","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2008.07.011_bib71","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.22326","article-title":"Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment","volume":"107","author":"Nakamura","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.07.011_bib72","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.11-10-1100","article-title":"Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue","volume":"11","author":"Cohen","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.hoc.2008.07.011_bib73","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone","volume":"16","author":"Schechter","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib74","series-title":"MALT lymphomas","first-page":"104","article-title":"Radiation therapy of mucosa-associated lymphoid tissue (MALT) lymphomas","author":"Gospodarowicz","year":"2004"},{"key":"10.1016\/j.hoc.2008.07.011_bib75","series-title":"MALT lymphomas","first-page":"99","article-title":"MALT lymphomas: the role of chemotherapy","author":"Conconi","year":"2004"},{"key":"10.1016\/j.hoc.2008.07.011_bib76","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","article-title":"Efficacy of single-agent chemotherapy in low-grade B-cell mucosa- associated lymphoid tissue lymphoma with prominent gastric expression","volume":"13","author":"Hammel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib77","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/cncr.20237","article-title":"Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma","volume":"100","author":"Zinzani","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.07.011_bib78","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","article-title":"Treatment of extranodal marginal zone B-Cell lymphoma of mucosa- associated lymphoid tissue type with cladribine: a phase II study","volume":"20","author":"Jager","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib79","first-page":"ECR01","article-title":"Occurence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature","volume":"89","author":"Jager","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2008.07.011_bib80","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/annonc\/mdg492","article-title":"Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP)","volume":"14","author":"Wohrer","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/asheducation-2005.1.307","article-title":"Clinical presentation and management of marginal zone lymphomas","author":"Thieblemont","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.hoc.2008.07.011_bib82","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib83","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","article-title":"Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma","volume":"65","author":"Raderer","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.hoc.2008.07.011_bib84","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdm513","article-title":"Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy","volume":"19","author":"Ferreri","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib85","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1182\/blood-2004-07-2755","article-title":"Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms","volume":"105","author":"Al-Saleem","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib86","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2008.07.011_bib88","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","article-title":"Splenic marginal zone cell lymphoma","volume":"16","author":"Schmid","year":"1992","journal-title":"Am J\u00a0Surg Pathol"},{"key":"10.1016\/j.hoc.2008.07.011_bib89","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"135","article-title":"Splenic marginal zone lymphoma","author":"Isaacson","year":"2001"},{"key":"10.1016\/j.hoc.2008.07.011_bib90","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","article-title":"Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis","volume":"106","author":"Ruiz-Ballesteros","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hon.762","article-title":"Nodal and splenic marginal zone B cell lymphomas","volume":"23","author":"Mollejo","year":"2005","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib92","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hoc.2008.07.011_bib93","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen","volume":"97","author":"Chan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib94","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1309\/REV9-FDTM-5NGC-HBWY","article-title":"Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma","volume":"113","author":"Karavattathayyil","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hoc.2008.07.011_bib95","first-page":"147","article-title":"Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland","volume":"85","author":"Zucca","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2008.07.011_bib96","first-page":"880","article-title":"Absence of hepatitis C virus infection in non-Hodgkin's lymphoma","volume":"96","author":"Thalen","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2008.07.011_bib97","series-title":"MALT lymphomas","first-page":"1","article-title":"MALT lymphoma: epidemiology and infectious agents","author":"Luppi","year":"2004"},{"key":"10.1016\/j.hoc.2008.07.011_bib98","first-page":"80","article-title":"Marginal zone-related neoplasms of splenic and nodal origin","volume":"88","author":"Arcaini","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2008.07.011_bib99","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","article-title":"Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles","volume":"100","author":"Arcaini","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.07.011_bib100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.011_bib101","series-title":"Human lymphoma: clinical implications of the REAL classification","first-page":"7.1","article-title":"Splenic marginal zone B cell lymphoma","author":"Isaacson","year":"1999"},{"key":"10.1016\/j.hoc.2008.07.011_bib102","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chacon","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib103","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib104","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.011_bib105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","article-title":"Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC)","volume":"93","author":"Troussard","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2008.07.011_bib106","first-page":"148","article-title":"Splenic lymphoma with circulating villous lymphocytes\/splenic marginal-zone lymphoma","volume":"36","author":"Catovsky","year":"1999","journal-title":"Semin Haematol"},{"key":"10.1016\/j.hoc.2008.07.011_bib107","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.1991.tb04417.x","article-title":"Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases","volume":"78","author":"Mulligan","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2008.07.011_bib108","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.leu.2401710","article-title":"Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes","volume":"14","author":"Lefrere","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2008.07.011_bib109","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3816\/CLM.2004.n.005","article-title":"Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma","volume":"4","author":"Arcaini","year":"2004","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.hoc.2008.07.011_bib110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hon.820","article-title":"Rituximab monotherapy is highly effective in splenic marginal zone lymphoma","volume":"25","author":"Kalpadakis","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib111","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/hon.844","article-title":"Rituximab monotherapy is highly effective in splenic marginal zone lymphoma","volume":"26","author":"Bennett","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib112","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","article-title":"Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project","volume":"17","author":"Nathwani","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib113","series-title":"Non-Hodgkin's lymphomas","first-page":"361","article-title":"Nodal marginal zone B-Cell lymphoma","author":"Berger","year":"2004"},{"key":"10.1016\/j.hoc.2008.07.011_bib114","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02780533","article-title":"Retreatment with chimeric CD 20 monoclonal antibody in a patient with nodal marginal zone B-cell lymphoma","volume":"17","author":"Koh","year":"2000","journal-title":"Med Oncol"},{"key":"10.1016\/j.hoc.2008.07.011_bib115","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of Anti-Hepatitis C Virus (HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880800107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880800107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:52:24Z","timestamp":1760183544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985880800107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S088985880800107X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2008.07.011","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marginal Zone Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2008.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}